- LATEST
- WEBSTORY
- TRENDING
BUSINESS
Meet man who joined company in 2015, then transformed it into a multi-crore global pharma powerhouse, he is...
This man has been the MD & Global CEO of Cipla since 2016, overseeing its significant market presence and commitment to developing essential medications worldwide.
Updated : Sep 29, 2024, 11:25 AM IST
 "Umang Vohra")
TRENDING NOW
)
Sudhanshu Pandey makes big statement on Anupamaa co-actor Rupali Ganguly's stepdaughter allegations: 'It's not good...'
)
Shweta Tiwari's wedding photos with Bigg Boss 13 contestant Vishal Aditya Singh go viral, here's the truth behind them
)
This Pakistani Influencer's private video leaked online, days after Minahil Malik and Insha Rehman's clips
)
Meet richest footballer of 2024, not Cristiano Ronaldo, Lionel Messi, his net worth is...
)
Gautam Adani's BIG Rs 16877 crore plan to take on Mukesh Ambani, set to build Mumbai's largest...
)
'Good to be back': After breaking up with Malaika Arora, Arjun Kapoor reunites with his 'partner-in-crime after ages'
)
Amid divorce rumours with Aishwarya Rai, Abhishek Bachchan tells Amitabh Bachchan: 'I hope people don't...'
)
'Kash ye Aishwarya ke liye...': Amitabh Bachchan shares early review of 'pride' Abhishek Bachchan's film, netizens react
)
Virat Kohli's tweet mistaken for 'divorce announcement' from Anushka Sharma, fans compare to AR Rahman's separation post
)
Amid divorce rumours with Aishwarya Rai, Abhishek Bachchan says he'll do 'whatever it takes' to be there for Aaradhya
)
Samantha Ruth Prabhu shares inspirational poem ahead of Naga Chaitanya, Sobhita Dhulipala wedding: 'Force your heart...'
)
Model's bold dance in towel at India Gate raises eyebrows, netizens say arrest her, watch viral video
)
AR Rahman, Saira Banu to separate 29 years after marriage due to 'significant emotional strain': 'Couple has found...'
)
Meet Imsha Rehman, Pakistani TikTok star who deactivated her accounts after video leak and Minahil Malik's MMS
)
Meet man, who made first mobile call in India from Nokia 29 years ago, it cost Rs...
Umang Vohra serves as the MD & Global CEO of Cipla since 2016, one of India’s leading multinational pharmaceutical companies based in Mumbai. Since taking the helm in September 2016, Vohra has focused on driving Cipla’s strategic growth and ensuring the company remains competitive in its core markets.
As of September 2024, Cipla has achieved annual revenue for FY24 as INR 25,455 crore. Hoping and executing a comprehensive roadmap that aims to sustain the company’s momentum in the pharmaceutical industry.
Vohra joined joined as CFO in Oct 2015, bringing nearly 20 years of valuable experience in the pharmaceutical sector and he now has close to 3 decades of experienc. He has a solid educational background, holding a Bachelor of Engineering in Computer Science from MSRIT in Bangalore, as well as an MBA from TA PAI Management Institute. Prior to his tenure at Cipla, Vohra held key positions at several renowned companies, including Eicher Motors, PepsiCo, and Dr. Reddy’s Laboratories, where he honed his skills in various aspects of the global pharmaceutical business.
A strong advocate for innovation, Vohra believes in the potential of agile business models, disruptive technologies, and data-driven analytics. He emphasizes the importance of fostering a future-ready workforce, all with the ultimate goal of improving patient lives through better healthcare solutions.
Cipla specializes in developing a wide range of medicines, particularly for conditions such as respiratory diseases, arthritis, diabetes, and depression, among others. The company boasts a robust global presence, with 47 manufacturing facilities located worldwide and its products available in 86 countries.
Cipla was originally established by Khwaja Abdul Hamied as Chemical, Industrial and Pharmaceutical Laboratories in Mumbai. In July 1984, the company rebranded itself to become known as Cipla Limited, marking the beginning of a new chapter in its journey as a key player in the pharmaceutical industry. Today, under Vohra's guidance, Cipla continues to grow and innovate, striving to meet the evolving needs of patients around the globe.
